Eurosurv. Increase of respiratory illnesses among children in Beijing, China, during the autumn and winter of 2023

[tetano]

• Cheng Gong[SUP]1,2,3[/SUP] , Fang Huang[SUP]1,2,3[/SUP] , Luodan Suo[SUP]1,2[/SUP] , Xuejiao Guan[SUP]1[/SUP] , Lu Kang[SUP]1,2[/SUP] , Hui Xie[SUP]1[/SUP] , Geng Hu[SUP]1[/SUP] , Peng Yang[SUP]1,2[/SUP] , Quanyi Wang[SUP]1,2[/SUP]

​In 2023, through an ongoing respiratory pathogen surveillance system, we observed from mid-September onwards, an increase of respiratory illness among children aged ≤ 15 years presenting at hospital outpatient clinics in Beijing, China. Data indicated that illness was caused by multiple pathogens, predominantly Mycoplasma pneumoniae. Seasonality, periodicity and high prevalence of resistance to macrolide (30 of 30 strains sequenced with the A2063G mutation) were important characteristics of the M. pneumoniae epidemic, which resulted in a rise in consultations at specialised paediatric hospitals.​

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.2.2300704

 

[sharon sanders]

Please see:

China - Mycoplasma pneumonia, influenza or COVID-19?: Beijing expert says to confirm before treatment - November 13, 2023
​
China - Pneumonia, Respiratory, and Influenza Like Illnesses (ILI) forum and scroll down

​